Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
Jeong Seok Lee
1
,
Seongwan Park
2
,
Hye Won Jeong
3
,
Jin Young Ahn
4
,
Seong Jin Choi
1
,
Hoyoung Lee
1
,
Baekgyu Choi
2
,
Su Kyung Nam
2
,
Moa Sa
1, 5
,
Jisoo A. Kwon
1, 6
,
Su Hyun Jeong
4
,
Heung Kyu Lee
1, 5
,
Sung Ho Park
7
,
Su-Jin Park
1, 5
,
Jun Hyuck Choi
4
,
Sung-Han Kim
6
,
Inkyung Jung
2
,
Eui-Cheol Shin
1, 5
4
6
Publication type: Journal Article
Publication date: 2020-07-03
scimago Q1
wos Q1
SJR: 8.220
CiteScore: 26.9
Impact factor: 16.3
ISSN: 24709468
PubMed ID:
32651212
General Medicine
Immunology
Abstract
Single-cell RNA sequencing of blood immune cells reveals type I interferon–associated hyper-inflammation in severe COVID-19.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
10
20
30
40
50
60
70
80
|
|
|
Frontiers in Immunology
80 publications, 10.47%
|
|
|
bioRxiv
23 publications, 3.01%
|
|
|
Nature Communications
21 publications, 2.75%
|
|
|
International Journal of Molecular Sciences
14 publications, 1.83%
|
|
|
Scientific Reports
14 publications, 1.83%
|
|
|
Nature
11 publications, 1.44%
|
|
|
Viruses
10 publications, 1.31%
|
|
|
Signal Transduction and Targeted Therapy
10 publications, 1.31%
|
|
|
medRxiv : the preprint server for health sciences
10 publications, 1.31%
|
|
|
iScience
8 publications, 1.05%
|
|
|
Journal of Medical Virology
8 publications, 1.05%
|
|
|
Cell
7 publications, 0.92%
|
|
|
EBioMedicine
7 publications, 0.92%
|
|
|
Briefings in Bioinformatics
7 publications, 0.92%
|
|
|
Science Translational Medicine
7 publications, 0.92%
|
|
|
Journal of Virology
7 publications, 0.92%
|
|
|
Genome Medicine
6 publications, 0.79%
|
|
|
Cell Reports
6 publications, 0.79%
|
|
|
Heliyon
6 publications, 0.79%
|
|
|
Cell Reports Medicine
6 publications, 0.79%
|
|
|
Journal of Immunology
5 publications, 0.65%
|
|
|
JCI insight
5 publications, 0.65%
|
|
|
Journal of Clinical Investigation
5 publications, 0.65%
|
|
|
Frontiers in Medicine
5 publications, 0.65%
|
|
|
Nature Immunology
5 publications, 0.65%
|
|
|
PLoS Pathogens
5 publications, 0.65%
|
|
|
Vaccines
4 publications, 0.52%
|
|
|
PLoS ONE
4 publications, 0.52%
|
|
|
Frontiers in Cellular and Infection Microbiology
4 publications, 0.52%
|
|
|
10
20
30
40
50
60
70
80
|
Publishers
|
20
40
60
80
100
120
140
160
|
|
|
Springer Nature
148 publications, 19.37%
|
|
|
Elsevier
129 publications, 16.88%
|
|
|
Cold Spring Harbor Laboratory
129 publications, 16.88%
|
|
|
Frontiers Media S.A.
108 publications, 14.14%
|
|
|
MDPI
41 publications, 5.37%
|
|
|
Wiley
36 publications, 4.71%
|
|
|
Oxford University Press
23 publications, 3.01%
|
|
|
American Society for Microbiology
16 publications, 2.09%
|
|
|
American Association for the Advancement of Science (AAAS)
14 publications, 1.83%
|
|
|
Taylor & Francis
12 publications, 1.57%
|
|
|
Public Library of Science (PLoS)
11 publications, 1.44%
|
|
|
American Society for Clinical Investigation
10 publications, 1.31%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
8 publications, 1.05%
|
|
|
The American Association of Immunologists
5 publications, 0.65%
|
|
|
American Thoracic Society
5 publications, 0.65%
|
|
|
Rockefeller University Press
4 publications, 0.52%
|
|
|
American Chemical Society (ACS)
4 publications, 0.52%
|
|
|
Mary Ann Liebert
3 publications, 0.39%
|
|
|
XMLink
3 publications, 0.39%
|
|
|
Annual Reviews
3 publications, 0.39%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 0.39%
|
|
|
Impact Journals
2 publications, 0.26%
|
|
|
BMJ
2 publications, 0.26%
|
|
|
Central Research Institute for Epidemiology
2 publications, 0.26%
|
|
|
The Korean Association of Immunobiologists
2 publications, 0.26%
|
|
|
European Molecular Biology Organization
2 publications, 0.26%
|
|
|
The Company of Biologists
1 publication, 0.13%
|
|
|
Association for Research in Vision and Ophthalmology (ARVO)
1 publication, 0.13%
|
|
|
Portland Press
1 publication, 0.13%
|
|
|
20
40
60
80
100
120
140
160
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
764
Total citations:
764
Citations from 2024:
154
(20.16%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Lee J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 // Science immunology. 2020. Vol. 5. No. 49.
GOST all authors (up to 50)
Copy
Lee J. S., Park S., Jeong H. W., Ahn J. Y., Choi S. J., Lee H., Choi B., Nam S. K., Sa M., Kwon J. A., Jeong S. H., Lee H. K., Park S. H., Park S., Choi J. H., Kim S., Jung I., Shin E. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 // Science immunology. 2020. Vol. 5. No. 49.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1126/sciimmunol.abd1554
UR - https://doi.org/10.1126/sciimmunol.abd1554
TI - Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
T2 - Science immunology
AU - Lee, Jeong Seok
AU - Park, Seongwan
AU - Jeong, Hye Won
AU - Ahn, Jin Young
AU - Choi, Seong Jin
AU - Lee, Hoyoung
AU - Choi, Baekgyu
AU - Nam, Su Kyung
AU - Sa, Moa
AU - Kwon, Jisoo A.
AU - Jeong, Su Hyun
AU - Lee, Heung Kyu
AU - Park, Sung Ho
AU - Park, Su-Jin
AU - Choi, Jun Hyuck
AU - Kim, Sung-Han
AU - Jung, Inkyung
AU - Shin, Eui-Cheol
PY - 2020
DA - 2020/07/03
PB - American Association for the Advancement of Science (AAAS)
IS - 49
VL - 5
PMID - 32651212
SN - 2470-9468
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Lee,
author = {Jeong Seok Lee and Seongwan Park and Hye Won Jeong and Jin Young Ahn and Seong Jin Choi and Hoyoung Lee and Baekgyu Choi and Su Kyung Nam and Moa Sa and Jisoo A. Kwon and Su Hyun Jeong and Heung Kyu Lee and Sung Ho Park and Su-Jin Park and Jun Hyuck Choi and Sung-Han Kim and Inkyung Jung and Eui-Cheol Shin},
title = {Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19},
journal = {Science immunology},
year = {2020},
volume = {5},
publisher = {American Association for the Advancement of Science (AAAS)},
month = {jul},
url = {https://doi.org/10.1126/sciimmunol.abd1554},
number = {49},
doi = {10.1126/sciimmunol.abd1554}
}